Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®
Clinical trial NCT02979535 · COMPLETED
Trial details
- NCT number
- NCT02979535
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-16
- Primary completion
- 2019-03-25
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.